These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 17418482)

  • 1. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
    van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
    Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
    van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
    Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity?
    Tanaka Y; Masumori N; Itoh N; Furuya S; Ogura H; Tsukamoto T
    Int J Urol; 2006 Nov; 13(11):1398-404. PubMed ID: 17083391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
    van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
    Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g.
    Gupta N; Sivaramakrishna ; Kumar R; Dogra PN; Seth A
    BJU Int; 2006 Jan; 97(1):85-9. PubMed ID: 16336334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.
    Hoekstra RJ; Van Melick HH; Kok ET; Ruud Bosch JL
    BJU Int; 2010 Sep; 106(6):822-6. PubMed ID: 20184573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement--a prospective randomized study.
    Liedberg F; Adell L; Hagberg G; Palmqvist IB
    Scand J Urol Nephrol; 2003; 37(6):494-7. PubMed ID: 14675923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome.
    Furuya R; Masumori N; Furuya S; Oda T; Takahashi S; Takeuchi M
    Urology; 2007 Nov; 70(5):922-6. PubMed ID: 18068448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar plasmakinetic transurethral resection of the prostate vs. transurethral enucleation and resection of the prostate: pre- and postoperative comparisons of parameters used in assessing benign prostatic enlargement.
    Zhang KY; Xing JC; Chen BS; Liu CX; Lau HW; Sim HG; Foo KT
    Singapore Med J; 2011 Oct; 52(10):747-687514. PubMed ID: 22009396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia.
    Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT
    Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered prostate specific antigen reference range after transurethral resection of the prostate.
    Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
    Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of prostatic cancer screening in patients treated for benign prostatic hyperplasia with medical or minimally invasive modalities.
    Orihuela E; Kocurek JN; Warren MM
    Arch Esp Urol; 1997 Sep; 50(7):821-4. PubMed ID: 9350090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference range of prostate-specific antigen after transurethral resection of the prostate.
    Aus G; Bergdahl S; Frösing R; Lodding P; Pileblad E; Hugosson J
    Urology; 1996 Apr; 47(4):529-31. PubMed ID: 8638362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of urinary symptoms after transurethral resection of the prostate and its correlation with clinical parameters].
    Zhao Z; Wang G; Na YQ
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):957-9. PubMed ID: 17961379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
    Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?
    Rigatti L; Naspro R; Salonia A; Centemero A; Ghezzi M; Guazzoni G; Briganti A; Rigatti P; Montorsi F
    Urology; 2006 Jun; 67(6):1193-8. PubMed ID: 16750253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year follow-up of feedback microwave thermotherapy versus TURP for clinical BPH: a prospective randomized multicenter study.
    Wagrell L; Schelin S; Nordling J; Richthoff J; Magnusson B; Schain M; Larson T; Boyle E; Duelund J; Kroyer K; Ageheim H; Mattiasson A
    Urology; 2004 Oct; 64(4):698-702. PubMed ID: 15491704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.